BARBARA FLEURAGUSTE: Open Payments
NPI 1205402849 · NEWTON, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$116 in 6 payments from 4 companies in 2025. Trend: 2023 $0 · 2024 $72 · 2025 $116
Food & beverage: $116
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $53 |
| Indivior Inc. | 1 | $26 |
| Alkermes, Inc. | 1 | $19 |
| Otsuka America Pharmaceutical, Inc. | 1 | $18 |
Products named: CAPLYTA, SUBLOCADE, ARISTADA, REXULTI.
Industry payments across MA — which companies pay providers there.
